1. Naringenin ameliorates hypoxia/reoxygenation-induced endoplasmic reticulum stress-mediated apoptosis in H9c2 myocardial cells: involvement in ATF6, IRE1α and PERK signaling activation
    Jia-You Tang et al, 2017, Mol Cell Biochem CrossRef
  2. The cardioprotective effect of naringenin against ischemia–reperfusion injury through activation of ATP-sensitive potassium channel in rat
    Li-Min Meng et al, 2016, Can. J. Physiol. Pharmacol. CrossRef
  3. Odanacatib Inhibits Resistin-induced Cardiomyocyte Hypertrophy Through the Inactivation of ERK Signaling Pathway
    Xian Zheng et al, 2017, International J. of Pharmacology CrossRef
  4. The Role of ERK1/2 in the Development of Diabetic Cardiomyopathy.
    Zheng Xu et al, 2016, Int J Mol Sci CrossRef
  5. Tailoring naringenin conjugates with amplified and triple antiplatelet activity profile: Rational design, synthesis, human plasma stability and in vitro evaluation
    Evgenios Stylos et al, 2017, Biochimica et Biophysica Acta (BBA) - General Subjects CrossRef
  6. Acacetin protects against cardiac remodeling after myocardial infarction by mediating MAPK and PI3K/Akt signal pathway
    Wei Chang et al, 2017, Journal of Pharmacological Sciences CrossRef
  7. Naringenin attenuates fibroblast activation and inflammatory response in a mechanical stretch-induced hypertrophic scar mouse model
    Shengzhou Shan et al, 2017 CrossRef
  8. Reappraisal of metallothionein: Clinical implications for patients with diabetes mellitus
    Yongsoo Park et al, 2018, Journal of Diabetes CrossRef
  9. Therapeutic Potential of Polyphenols in Cardiac Fibrosis
    Ning Zhang et al, 2018, Front. Pharmacol. CrossRef
  10. Naringenin exhibits the protective effect on cardiac hypertrophy via EETs-PPARs activation in streptozocin-induced diabetic mice
    Jie Zhang et al, 2018, Biochemical and Biophysical Research Communications CrossRef
  11. Combating oxidative stress disorders with citrus flavonoid: Naringenin
    Nurul Hannim Zaidun et al, 2018, Life Sciences CrossRef
  12. Dexmedetomidine restores autophagy and cardiac dysfunction in rats with streptozotocin-induced diabetes mellitus
    Ju Eun Oh et al, 2018, Acta Diabetol CrossRef
  13. EETs/PPARs activation together mediates the preventive effect of naringenin in high glucose-induced cardiomyocyte hypertrophy
    Jie Zhang et al, 2019, Biomedicine & Pharmacotherapy CrossRef
  14. Allicin attenuates pathological cardiac hypertrophy by inhibiting autophagy via activation of PI3K/Akt/mTOR and MAPK/ERK/mTOR signaling pathways
    Lina Ba et al, 2018, Phytomedicine CrossRef
  15. Naringenin Attenuates Myocardial Ischemia-Reperfusion Injury via cGMP-PKGIα Signaling and In Vivo and In Vitro Studies
    Li-Ming Yu et al, 2019, Oxidative Medicine and Cellular Longevity CrossRef
  16. null
    Erika Ramos-Tovar et al, 2019 CrossRef
  17. Cardioprotective Efficacy of Naringenin Against Isoproterenol Induced Chronic Heart Failure in a Rat Model
    Yi Hao et al, 2019, International J. of Pharmacology CrossRef
  18. null
    E. Hernández-Aquino et al, 2017 CrossRef
  19. Stachydrine ameliorates isoproterenol-induced cardiac hypertrophy and fibrosis by suppressing inflammation and oxidative stress through inhibiting NF-κB and JAK/STAT signaling pathways in rats.
    Lingling Zhao et al, 2017, Int Immunopharmacol CrossRef
  20. Naringenin attenuates the progression of liver fibrosis via inactivation of hepatic stellate cells and profibrogenic pathways
    Erika Hernández-Aquino et al, 2019, European Journal of Pharmacology CrossRef
  21. Mechanisms contributing to cardiac remodelling
    Qing-Qing Wu et al, 2017 CrossRef
  22. Naringenin inhibits transforming growth factor‑β1‑induced cardiac fibroblast proliferation and collagen synthesis via G0/G1 arrest
    Mingxin Liu et al, 2017, Exp Ther Med CrossRef
  23. Naringenin inhibits NG‑nitro‑L‑arginine methyl ester‑induced hypertensive left ventricular hypertrophy by decreasing angiotensin‑converting enzyme 1 expression
    Yanxiang Gao et al, 2018, Exp Ther Med CrossRef
  24. Naringenin and naringin in cardiovascular disease prevention: A preclinical review
    Reza Heidary Moghaddam et al, 2020, European Journal of Pharmacology CrossRef
  25. Multi-Therapeutic Potential of Naringenin (4′,5,7-Trihydroxyflavonone): Experimental Evidence and Mechanisms
    Azher Arafah et al, 2020, Plants CrossRef
  26. Nutritional Composition and Bioactive Compounds in Tomatoes and Their Impact on Human Health and Disease: A Review
    Md Yousuf Ali et al, 2020, Foods CrossRef
  27. Comparative Analysis on Single- and Multiherb Strategies in Coronary Artery Atherosclerosis Therapy
    Yu Cao et al, 2021, Cardiology Research and Practice CrossRef
  28. The Gastroprotective Effect of Naringenin against Ethanol-Induced Gastric Ulcers in Mice through Inhibiting Oxidative and Inflammatory Responses
    Wei-Sung Li et al, 2021, IJMS CrossRef
  29. Naringenin: A Promising Therapeutic Agent against Organ Fibrosis
    Yanfei Du et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef
  30. Modulation of integrin receptor by polyphenols: Downstream Nrf2-Keap1/ARE and associated cross-talk mediators in cardiovascular diseases
    Sajad Fakhri et al, 2022, Critical Reviews in Food Science and Nutrition CrossRef
  31. Banxia baizhu tianma decoction, a Chinese herbal formula, for hypertension: Integrating meta-analysis and network pharmacology
    Jianguo Lin et al, 2022, Front. Pharmacol. CrossRef
  32. Naringenin Attenuates Isoprenaline-Induced Cardiac Hypertrophy by Suppressing Oxidative Stress through the AMPK/NOX2/MAPK Signaling Pathway
    Yu Li et al, 2023, Nutrients CrossRef
  33. Biological activities of naringenin: A narrative review based on in vitro and in vivo studies
    Kübra Uçar et al, 2023, Nutrition Research CrossRef
  34. Modulation of the c-JNK/p38-MAPK Signaling Pathway: Investigating the Therapeutic Potential of Natural Products in Hypertension
    Rakesh Sahu et al, 2024, Phytomedicine Plus CrossRef
  35. Homotherapy for Heteropathy: A Molecular Mechanism of Poria Sini Decoction for Treatment of Liver Cancer and Chronic Heart Failure
    Zhe Zhao et al, 2024, Evidence-Based Complementary and Alternative Medicine CrossRef